The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria - Journal of Allergy and Clinical Immunology
Omalizumab beyond asthma | Allergologia et Immunopathologia
Omalizumab Mechanism of Action In IgE-Mediated Asthma
Omalizumab in Asthma: An Update on Recent Developments - ScienceDirect
Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria - Kaplan - 2017 - Allergy - Wiley Online Library
Effectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthma - ScienceDirect
Proposed mechanisms of action of omalizumab. Omalizumab decreases free... | Download Scientific Diagram
New insights into the utility of omalizumab - Journal of Allergy and Clinical Immunology
Drug Profile: Xolair - Benjamin Yang - Discovery Medicine
The Expanding Field of Biologics in the Management of Chronic Urticaria - The Journal of Allergy and Clinical Immunology: In Practice
Frontiers | Molecular Targets for Biological Therapies of Severe Asthma | Immunology
Xolair - Biological Therapy - Clinical Trials Arena
Omalizumab, an anti-immunoglobulin E antibody: state of the art | DDDT
Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange | Nature Communications
Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria - Kaplan - 2017 - Allergy - Wiley Online Library
Omalizumab Overview - Creative Biolabs
Mechanism of action of omalizumab. Abbreviation: ige, immunoglobulin e. | Download Scientific Diagram
Omalizumab in Practice Use
Roles of omalizumab in various allergic diseases - ScienceDirect
Omalizumab in the Treatment of Chronic Urticaria - ScienceDirect
Anti-Immunoglobulin E Therapy - World Allergy Organization Journal
The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update - Respiratory Medicine
Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence - Journal of Allergy and Clinical Immunology
Omalizumab dampens type 2 inflammation in a group of long‐term treated asthma patients and detaches IgE from FcεRI - Maggi - 2018 - European Journal of Immunology - Wiley Online Library
